Stay updated on Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The study page now shows 'No longer looking for participants', signaling that recruitment is closed for this study. Additional navigational or labeling updates were applied, including new sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and a minor heading formatting change from 'Intervention / Treatment' to 'Intervention/Treatment'.
    Difference
    0.2%
    Check dated 2026-06-10T18:09:56.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.5.5, replacing Revision: v3.5.4. This indicates a minor update to the page's revision history without changing its content.
    Difference
    0.0%
    Check dated 2026-06-03T09:54:53.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The study locations list now includes Taebuk, Chungcheongbuk-do, South Korea (28644) and previously listed Jungbuk (28644) was removed; the page revision was updated from v3.5.3 to v3.5.4.
    Difference
    0.0%
    Check dated 2026-05-19T23:08:52.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The revision tag has been updated to v3.5.3, replacing the previous v3.5.0 in the revision history. This represents a metadata update with no substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-04-28T10:46:09.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    The Veneto, Italy site listing changed from Padua to Padova (postal code 35128).
    Difference
    0.0%
    Check dated 2026-04-06T03:10:48.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    A new publication citation has been added to the Publications section: 'Assessing side-effect bother, burden, and tolerability: A qualitative study exploring the content validity of the Functional Assessment of Cancer Therapy - Item GP5.' This reference provides additional context for the study's reported outcomes but does not modify study design or participant information.
    Difference
    0.0%
    Check dated 2026-03-30T01:57:07.000Z thumbnail image

Stay in the know with updates to Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET-Mutant Medullary Thyroid Cancer Clinical Trial page.